ResearcherEdinburgh Cancer ResearchNo recent work listed

Catherine Davidson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8354-8228; OpenAlex author ID A5069475601. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer. Co-author DOI 10.1136/gutjnl-2022-327927 ↗
FAK promotes stromal PD-L2 expression associated with poor survival in pancreatic cancer. Co-author DOI 10.1038/s41416-022-01966-5 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Marta Canel · 2 shared papers, 2022–2023 · strength 0.36
- Paper FAK promotes stromal PD-L2 expression associated with poor survival in pancreatic cancer. DOI 10.1038/s41416-022-01966-5 ↗
- Paper FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer. DOI 10.1136/gutjnl-2022-327927 ↗
Alan Serrels · 2 shared papers, 2022–2023 · strength 0.36
- Paper FAK promotes stromal PD-L2 expression associated with poor survival in pancreatic cancer. DOI 10.1038/s41416-022-01966-5 ↗
- Paper FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer. DOI 10.1136/gutjnl-2022-327927 ↗
Andrew Victor Biankin · 1 shared paper, 2023 · strength 0.17
- Paper FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer. DOI 10.1136/gutjnl-2022-327927 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.